Assignee
BIOPHYTIS
FR·8 granted patents·6 pending applications·6 citations·filing 2015–2023
Top patents by PatentIndex Score
14 records- 0176US9938315B2Chemical compounds and use thereof for improving muscular qualityBIOPHYTIS·Filed 2015·Granted Apr 10, 2018·3 cites·13 claims
- 0269US10316056B2Chemical compounds and use thereof for improving muscular qualityBIOPHYTIS·Filed 2018·Granted Jun 11, 2019·1 cites·15 claims
- 0365US11542295B2Use of 20-hydroxyecdysone and the derivatives thereof in the treatment of myopathiesBIOPHYTIS·Filed 2018·Granted Jan 3, 2023·1 cites·17 claims
- 0465US10513503B2Use of 3-deoxyanthocyanidins for treating occular diseasesBIOPHYTIS·Filed 2016·Granted Dec 24, 2019·1 cites·7 claims
- 0565US2023158046A1Phytoecdysones for use in the prevention of muscle strength loss during immobilisationBIOPHYTIS·Filed 2023·Application pending·0 cites
- 0656US2020148718A1Pharmaceutical-grade 20-hydroxyecdysone extract, use of same and preparation thereofBIOPHYTIS·Filed 2018·Application pending·0 cites
- 0756US2025207127A1Phytoecdysones and/or 20-hydroxyecdysone derivatives in combination with an active ingredient for restoring smn expression, for use in the treatment of spinal muscular atrophyBIOPHYTIS·Filed 2022·Application pending·0 cites
- 0856US2021369735A1Phytoecdysones for use in the prevention of muscle strength loss during immobilisationBIOPHYTIS·Filed 2019·Application pending·0 cites
- 0950US12551495B2Phytoecdysones and derivatives thereof for use in treating disordered respiratory function on viral infectionBIOPHYTIS·Filed 2021·Granted Feb 17, 2026·0 cites·11 claims
- 1046US12440500B2Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseasesBIOPHYTIS·Filed 2020·Granted Oct 14, 2025·0 cites·18 claims
- 1145US12215067B2Chemical compounds targeting the eye and use thereof in the treatment of eye diseasesBIOPHYTIS·Filed 2020·Granted Feb 4, 2025·0 cites·20 claims
- 1245US2022152060A1Phytoecdysones and the derivatives thereof for use in the treatment of impaired lung functionBIOPHYTIS·Filed 2020·Application pending·0 cites
- 1344US2017354638A1Bixa orellana composition for the treatment macular degenerationBIOPHYTIS·Filed 2017·Application pending·0 cites
- 1440US10314804B2Composition containing norbixin for protecting cells of the retinal pigment epitheliumBIOPHYTIS·Filed 2016·Granted Jun 11, 2019·0 cites·11 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →